Yu Chen
Directeur/Bestuurslid bij Genor Biopharma Co., Ltd.
Actieve functies van Yu Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | - | - |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 01-07-2021 | - |
Loopbaan van Yu Chen
Eerdere bekende functies van Yu Chen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ZHAOKE OPHTHALMOLOGY LIMITED | Directeur/Bestuurslid | 23-10-2020 | 08-04-2024 |
GENOR BIOPHARMA HOLDINGS LIMITED | Directeur/Bestuurslid | 03-12-2018 | 02-01-2024 |
GEMPHARMATECH CO., LTD. | Directeur/Bestuurslid | 01-08-2020 | 04-04-2023 |
SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Directeur/Bestuurslid | 01-02-2020 | 30-03-2022 |
Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | 01-01-2012 | 01-07-2015 |
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Corporate Officer/Principal | 01-09-2010 | 01-06-2011 |
Opleiding van Yu Chen
The Hong Kong University of Science & Technology | Undergraduate Degree |
Yale University | Graduate Degree |
Stanford University | Graduate Degree |
Statistieken
Internationaal
China | 5 |
Hongkong | 4 |
Kaaimaneilanden | 3 |
Operationeel
Director/Board Member | 6 |
Graduate Degree | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 4 |
---|---|
GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
ZHAOKE OPHTHALMOLOGY LIMITED | Health Technology |
SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Commercial Services |
GEMPHARMATECH CO., LTD. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Citigroup Global Markets Asia Ltd.
Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Finance |
Shanghai Panxin Equity Investment Management Co. Ltd. | |
Genor Biopharma Co., Ltd.
Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |